Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
N Biotechnol ; 50: 60-69, 2019 May 25.
Article in English | MEDLINE | ID: mdl-30634000

ABSTRACT

CTX-M15 is one of the most widespread, extended spectrum ß-lactamases, a major determinant of antibiotic resistance representing urgent public health threats, among enterobacterial strains infecting humans and animals. Here we describe the selection of binders to CTX-M15 from a combinatorial affibody library displayed on ribosomes. Upon three increasingly selective ribosome display iterations, selected variants were identified by next generation sequencing (NGS). Nine affibody variants with high relative abundance bearing QRP and QLH amino acid motifs at residues 9-11 were produced and characterized in terms of stability, affinity and specificity. All affibodies were correctly folded, with affinities ranging from 0.04 to 2 µM towards CTX-M15, and successfully recognized CTX-M15 in bacterial lysates, culture supernatants and on whole bacteria. It was further demonstrated that the binding of affibody molecules to CTX-M15 modulated the enzyme's kinetic parameters. This work provides an approach using ribosome display coupled to NGS for the rapid generation of protein ligands of interest in diagnostic and research applications.


Subject(s)
Ribosomes/metabolism , beta-Lactamases/metabolism , Escherichia coli/enzymology , Klebsiella pneumoniae/enzymology , beta-Lactamases/isolation & purification
2.
Vaccine ; 36(25): 3622-3628, 2018 06 14.
Article in English | MEDLINE | ID: mdl-29759379

ABSTRACT

In the past decades protein nanoparticles have successfully been used for vaccine applications. Their particulate nature and dense repetitive subunit organization makes them perfect carriers for antigen surface display and confers high immunogenicity. Nanoparticles have emerged as excellent candidates for vectorization of biological and immunostimulating molecules. Nanoparticles and biomolecular nanostructures such as ferritins or virus like particles have been used as diagnostic and therapeutic delivery systems, in vaccine development, as nanoreactors, etc. Recently, a new class of bacterial protein compartment has been discovered referred to as encapsulin nanocompartment. These compartments have been used for targeted diagnostics, as therapeutic delivery systems and as nanoreactors. Their biological origin makes them conveniently biocompatible and allows genetic functionalization. The aim of our study was to implement encapsulin nanocompartements for simultaneous epitope surface display and heterologous protein loading for rational vaccine design. For this proof-of-concept-study, we produced Thermotoga maritima encapsulin nanoparticles in E. coli. We demonstrated the ability of simultaneous display in our system by inserting Matrix protein 2 ectodomain (M2e) of influenza A virus at the nanoparticle surface and by packaging of a fluorescent reporter protein (GFP) into the internal cavity. Characterization of the nanoparticles by electronic microscopy confirmed homogenously shaped particles of 24 nm diameter in average. The results further show that engineering of the particle surface improved the loading capacity of the heterologous reporter protein suggesting that surface display may induce a critical elastic deformation resulting in improved stiffness. In Balb/c mice, nanoparticle immunization elicited antibody responses against both the surface epitope and the loaded cargo protein. These results confirm the potential of encapsulin nanocompartments for customized vaccine design and antigen delivery.


Subject(s)
Antibodies, Viral/biosynthesis , Bacterial Proteins/genetics , Nanoparticles/chemistry , Plasmids/immunology , Vaccines, DNA/genetics , Viral Matrix Proteins/genetics , Amino Acid Sequence , Animals , Bacterial Proteins/immunology , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Genes, Reporter , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/immunology , Immunization , Mice , Mice, Inbred BALB C , Nanoparticles/administration & dosage , Nanoparticles/ultrastructure , Particle Size , Plasmids/administration & dosage , Plasmids/chemistry , Thermotoga maritima/genetics , Thermotoga maritima/metabolism , Vaccines, DNA/administration & dosage , Vaccines, DNA/immunology , Viral Matrix Proteins/immunology
3.
FEBS Lett ; 592(9): 1554-1564, 2018 05.
Article in English | MEDLINE | ID: mdl-29624661

ABSTRACT

Codon usage distribution has been soundly used by nature to fine tune protein biogenesis. Alteration of the mRNA structure or sequential scheduling of codons can profoundly affect translation, thus altering protein yield, functionality, solubility, and proper folding. Building on these observations, here, we present an evaluation of different recently designed algorithms of sequence adaptation based on Codon Adaptation Index (CAI) profiling. The first algorithm globally harmonizes synonymous codons in the original sequence in full respect to the heterologous expression host codon usage. The second recodes the sequence in accordance with the native sequence CAI profile. Our data, generated on three model proteins, highlights the importance to consider gene recoding as a parameter itself for recombinant protein expression improvement.


Subject(s)
Codon/genetics , Computational Biology/methods , Gene Expression Regulation , Algorithms , Base Sequence , Protein Biosynthesis , Solubility
4.
J Virol Methods ; 232: 8-11, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26947397

ABSTRACT

Virus-like particles (VLPs) are promising molecular structures for the design and construction of novel vaccines, diagnostic tools, and gene therapy vectors. Size, oligomer assembly and repetitiveness of epitopes are optimal features to induce strong immune responses. Several VLP-based vaccines are currently licensed and commercialized, and many vaccine candidates are now under preclinical and clinical studies. In recent years, the development of genetically engineered recombinant VLPs has accelerated the need for new, improved downstream processes. In particular, a rapid low cost purification process has been identified as a remaining key challenge in manufacturing process development. In the present study we set up a size-exclusion chromatography-based, scalable purification protocol for the purification of a VLP-based influenza A vaccine produced in Escherichia coli. Recombinant VLPs derived from the RNA bacteriophage MS2 displaying an epitope from the ectodomain of Matrix 2 protein from influenza A virus were produced and purified. The 3 steps purification protocol uses a recently developed multimodal size-exclusion chromatography medium (Capto™ Core 700) in combination with detergent extraction and size-exclusion polishing to reach a 89% VLP purity with a 19% yield. The combination of this downstream strategy following production in E. coli would be suited for production of VLP-based veterinary vaccines targeting livestock and companion animals where large amounts of doses must be produced at an affordable price.


Subject(s)
Chromatography, Gel/methods , Epitopes/immunology , Influenza A virus/immunology , Influenza Vaccines/isolation & purification , Vaccines, Virus-Like Particle/isolation & purification , Animals , Epitopes/genetics , Escherichia coli/genetics , Escherichia coli/metabolism , Influenza A virus/genetics , Influenza Vaccines/genetics , Levivirus/genetics , Orthomyxoviridae Infections/prevention & control , Orthomyxoviridae Infections/veterinary , Vaccines, Synthetic/genetics , Vaccines, Synthetic/isolation & purification , Vaccines, Virus-Like Particle/genetics , Veterinary Medicine/methods , Viral Matrix Proteins/genetics , Viral Matrix Proteins/immunology
5.
PLoS Genet ; 9(10): e1003913, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24204315

ABSTRACT

miRNAs are small regulatory RNAs that, due to their considerable potential to target a wide range of mRNAs, are implicated in essentially all biological process, including cancer. miR-10a is particularly interesting considering its conserved location in the Hox cluster of developmental regulators. A role for this microRNA has been described in developmental regulation as well as for various cancers. However, previous miR-10a studies are exclusively based on transient knockdowns of this miRNA and to extensively study miR-10a loss we have generated a miR-10a knock out mouse. Here we show that, in the Apc(min) mouse model of intestinal neoplasia, female miR-10a deficient mice develop significantly more adenomas than miR-10(+/+) and male controls. We further found that Lpo is extensively upregulated in the intestinal epithelium of mice deprived of miR-10a. Using in vitro assays, we demonstrate that the primary miR-10a target KLF4 can upregulate transcription of Lpo, whereas siRNA knockdown of KLF4 reduces LPO levels in HCT-116 cells. Furthermore, Klf4 is upregulated in the intestines of miR-10a knockout mice. Lpo has previously been shown to have the capacity to oxidize estrogens into potent depurinating mutagens, creating an instable genomic environment that can cause initiation of cancer. Therefore, we postulate that Lpo upregulation in the intestinal epithelium of miR-10a deficient mice together with the predominant abundance of estrogens in female animals mainly accounts for the sex-related cancer phenotype we observed. This suggests that miR-10a could be used as a potent diagnostic marker for discovering groups of women that are at high risk of developing colorectal carcinoma, which today is one of the leading causes of cancer-related deaths.


Subject(s)
Intestinal Neoplasms/genetics , Kruppel-Like Transcription Factors/biosynthesis , Lactoperoxidase/genetics , MicroRNAs/genetics , Animals , Disease Models, Animal , Female , Gene Expression Regulation, Neoplastic , HCT116 Cells , Humans , Intestinal Neoplasms/pathology , Kruppel-Like Factor 4 , Lactoperoxidase/biosynthesis , Male , Mice , Mice, Knockout , MicroRNAs/metabolism , Wnt Signaling Pathway/genetics
6.
PLoS One ; 7(5): e36684, 2012.
Article in English | MEDLINE | ID: mdl-22629323

ABSTRACT

MicroRNAs (miRNAs) are crucial for regulatory T cell (Treg) stability and function. We report that microRNA-10a (miR-10a) is expressed in Tregs but not in other T cells including individual thymocyte subsets. Expression profiling in inbred mouse strains demonstrated that non-obese diabetic (NOD) mice with a genetic susceptibility for autoimmune diabetes have lower Treg-specific miR-10a expression than C57BL/6J autoimmune resistant mice. Inhibition of miR-10a expression in vitro leads to reduced FoxP3 expression levels and miR-10a expression is lower in unstable "exFoxP3" T cells. Unstable in vitro TGF-ß-induced, iTregs do not express miR-10a unless cultured in the presence of retinoic acid (RA) which has been associated with increased stability of iTreg, suggesting that miR-10a might play a role in stabilizing Treg. However, genetic ablation of miR-10a neither affected the number and phenotype of natural Treg nor the capacity of conventional T cells to induce FoxP3 in response to TGFß, RA, or a combination of the two. Thus, miR-10a is selectively expressed in Treg but inhibition by antagomiRs or genetic ablation resulted in discordant effects on FoxP3.


Subject(s)
Diabetes Mellitus, Type 1/genetics , MicroRNAs/metabolism , T-Lymphocytes, Regulatory/metabolism , Animals , Cells, Cultured , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/metabolism , Gene Expression , Mice , Mice, Inbred NOD , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , Transforming Growth Factor beta/pharmacology , Tretinoin/pharmacology
8.
Trends Microbiol ; 20(3): 106-12, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22305804

ABSTRACT

Iron, zinc and copper, among others, are transition metals with multiple biological roles that make them essential elements for life. Beyond the strict requirement of transition metals by the vertebrate immune system for its proper functioning, novel mechanisms involving direct metal intoxication of microorganisms are starting to be unveiled as important components of the immune system, in particular against Mycobacterium tuberculosis. In parallel, metal detoxification systems in bacteria have been recently characterized as crucial microbial virulence determinants. Here, we will focus on these exciting advancements implicating copper- and zinc-mediated microbial poisoning as a novel innate immune mechanism against microbial pathogens, shedding light on an emerging field in the metallobiology of host-pathogen interactions.


Subject(s)
Copper/metabolism , Host-Pathogen Interactions , Iron/metabolism , Mycobacterium tuberculosis/metabolism , Tuberculosis/microbiology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Humans , Mycobacterium tuberculosis/genetics , Tuberculosis/metabolism
9.
Mol Microbiol ; 70(3): 762-74, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18808383

ABSTRACT

Mycobacterium tuberculosis and other pathogenic mycobacterial species produce large amounts of a glycogen-like alpha-glucan that represents the major polysaccharide of their outermost capsular layer. To determine the role of the surface-exposed glucan in the physiology and virulence of these bacteria, orthologues of the glg genes involved in the biosynthesis of glycogen in Escherichia coli were identified in M. tuberculosis H37Rv and inactivated by allelic replacement. Biochemical analyses of the mutants and complemented strains indicated that the synthesis of glucan and glycogen involves the alpha-1,4-glucosyltransferases Rv3032 and GlgA (Rv1212c), the ADP-glucose pyrophosphorylase GlgC (Rv1213) and the branching enzyme GlgB (Rv1326c). Disruption of glgC reduced by half the glucan and glycogen contents of M. tuberculosis, whereas the inactivation of glgA and Rv3032 affected the production of capsular glucan and glycogen, respectively. Attempts to disrupt Rv3032 in the glgA mutant were unsuccessful, suggesting that a functional copy of at least one of the two alpha-1,4-glucosyltransferases is required for growth. Importantly, the glgA mutant was impaired in its ability to persist in mice, suggesting a role for the capsular glucan in the persistence phase of infection. Unexpectedly, GlgB was found to be an essential enzyme.


Subject(s)
Bacterial Proteins/metabolism , Glucans/biosynthesis , Glycogen/biosynthesis , Mycobacterium tuberculosis/metabolism , Tuberculosis/microbiology , 1,4-alpha-Glucan Branching Enzyme/genetics , 1,4-alpha-Glucan Branching Enzyme/metabolism , Animals , Bacterial Proteins/genetics , Cells, Cultured , DNA, Bacterial/genetics , Female , Gene Knockout Techniques , Genes, Bacterial , Genetic Complementation Test , Glucose-1-Phosphate Adenylyltransferase/genetics , Glucose-1-Phosphate Adenylyltransferase/metabolism , Macrophages/microbiology , Mice , Mice, Inbred BALB C , Mutation , Mycobacterium tuberculosis/genetics
10.
J Biol Chem ; 282(37): 27270-27276, 2007 Sep 14.
Article in English | MEDLINE | ID: mdl-17640872

ABSTRACT

Mycobacteria produce two unusual polymethylated polysaccharides, the 6-O-methylglucosyl-containing lipopolysaccharides (MGLP) and the 3-O-methylmannose polysaccharides, which have been shown to regulate fatty acid biosynthesis in vitro. A cluster of genes dedicated to the synthesis of MGLP was identified in Mycobacterium tuberculosis and Mycobacterium smegmatis. Overexpression of the putative glycosyltransferase gene Rv3032 in M. smegmatis greatly stimulated MGLP production, whereas the targeted disruption of Rv3032 in M. tuberculosis and that of the putative methyltransferase gene MSMEG2349 in M. smegmatis resulted in a dramatic reduction in the amounts of MGLP synthesized and in the accumulation of precursors of these molecules. Disruption of Rv3032 also led to a significant decrease in the glycogen content of the tubercle bacillus, indicating that the product of this gene is likely to be involved in the elongation of more than one alpha-(1-->4)-glucan in this bacterium. Results thus suggest that Rv3032 encodes the alpha-(1-->4)-glucosyltransferase responsible for the elongation of MGLP, whereas MSMEG2349 encodes the O-methyltransferase required for the 6-O-methylation of these compounds.


Subject(s)
Lipopolysaccharides/biosynthesis , Methylglucosides/analysis , Mycobacterium tuberculosis/metabolism , Glycogen/analysis , Glycosyltransferases/genetics , Glycosyltransferases/physiology , Multigene Family , Mycobacterium tuberculosis/genetics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
11.
Tuberculosis (Edinb) ; 87(2): 78-86, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17030019

ABSTRACT

The cell envelope of pathogenic mycobacteria is highly distinctive in that it contains a number of lipids esterified with structurally related long-chain multi-methyl-branched fatty acids. These lipids have long been thought to play important roles in the cell envelope structure as well as in the pathogenicity of the tubercle bacillus. This review summarizes what is known about the biosynthesis of long-chain multiple methyl-branched fatty acid-containing lipids in Mycobacterium tuberculosis and describes the most recent findings about their regulation, transport across the different layers of the cell envelope and their biological functions.


Subject(s)
Lipid Metabolism , Membrane Lipids/metabolism , Mycobacterium tuberculosis/metabolism , Biological Transport/physiology , Fatty Acids/metabolism , Glycolipids/analysis , Glycolipids/chemistry , Glycolipids/metabolism , Lipids/analysis , Lipids/biosynthesis , Lipids/chemistry , Models, Chemical , Phenotype , Polyketide Synthases/metabolism , Sulfoglycosphingolipids/metabolism , Trehalose/metabolism , Virulence
12.
Microbes Infect ; 8(8): 2245-53, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16782391

ABSTRACT

p-Hydroxybenzoic acid derivatives (p-HBADs) are glycoconjugates secreted by all Mycobacterium tuberculosis isolates whose contribution to pathogenicity remains to be determined. The pathogenicity of three transposon mutants of M. tuberculosis deficient in the biosynthesis of some or all forms of p-HBADs was studied. Whilst the mutants grew similarly to the wild-type strain in macrophages and C57BL/6 mice, two of the mutants induced a more severe and diffuse inflammation in the lungs. The lack of production of some or all forms of p-HBADs in these two mutants also correlated with an increased secretion of the pro-inflammatory cytokines tumour-necrosis factor alpha, interleukin 6 and interleukin 12 in vivo. We propose that the loss of production of p-HBADs by tubercle bacilli results in their diminished ability to suppress the pro-inflammatory response to infection and that this ultimately provokes extensive pulmonary lesions in the C57BL/6 model of tuberculosis infection.


Subject(s)
Mutation , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/pathogenicity , Parabens/metabolism , Animals , Cells, Cultured , Colony Count, Microbial , Cytokines/biosynthesis , DNA Transposable Elements , Disease Models, Animal , Female , Lung/microbiology , Lung/pathology , Macrophages/immunology , Macrophages/microbiology , Mice , Mice, Inbred C57BL , Mutagenesis, Insertional , Mycobacterium tuberculosis/immunology , Mycobacterium tuberculosis/metabolism , Tuberculosis/microbiology
13.
EMBO J ; 25(7): 1436-44, 2006 Apr 05.
Article in English | MEDLINE | ID: mdl-16541102

ABSTRACT

Cell envelope lipids play an important role in the pathogenicity of mycobacteria, but the mechanisms by which they are transported to the outer membrane of these prokaryotes are largely unknown. Here, we provide evidence that LppX is a lipoprotein required for the translocation of complex lipids, the phthiocerol dimycocerosates (DIM), to the outer membrane of Mycobacterium tuberculosis. Abolition of DIM transport following disruption of the lppX gene is accompanied by an important attenuation of the virulence of the tubercle bacillus. The crystal structure of LppX unveils an U-shaped beta-half-barrel dominated by a large hydrophobic cavity suitable to accommodate a single DIM molecule. LppX shares a similar fold with the periplasmic molecular chaperone LolA and the outer membrane lipoprotein LolB, which are involved in the localization of lipoproteins to the outer membrane of Gram-negative bacteria. Based on the structure and although an indirect participation of LppX in DIM transport cannot yet be ruled out, we propose LppX to be the first characterized member of a family of structurally related lipoproteins that carry lipophilic molecules across the mycobacterial cell envelope.


Subject(s)
Lipids/physiology , Lipoproteins/physiology , Mycobacterium tuberculosis/metabolism , Animals , Biological Transport , Cell Membrane/metabolism , Crystallography, X-Ray , Female , Hydrophobic and Hydrophilic Interactions , Lipids/chemistry , Lipoproteins/chemistry , Lipoproteins/genetics , Lung/virology , Mice , Mice, Inbred BALB C , Models, Molecular , Mutation , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/pathogenicity , Protein Conformation , Protein Folding , Tuberculosis, Pulmonary/virology , Virulence
14.
J Biol Chem ; 280(49): 40699-706, 2005 Dec 09.
Article in English | MEDLINE | ID: mdl-16210318

ABSTRACT

Glycosylated p-hydroxybenzoic acid methyl esters and structurally related phenolphthiocerol glycolipids are important virulence factors of Mycobacterium tuberculosis. Although both types of molecules are thought to be derived from p-hydroxybenzoic acid, the origin of this putative biosynthetic precursor in mycobacteria remained to be established. We describe the characterization of a transposon mutant of M. tuberculosis deficient in the production of all forms of p-hydroxybenzoic acid derivatives. The transposon was found to be inserted in Rv2949c, a gene located in the vicinity of the polyketide synthase gene pks15/1, involved in the elongation of p-hydroxybenzoate to phenolphthiocerol in phenolic glycolipid-producing strains. A recombinant form of the Rv2949c enzyme was produced in the fast-growing non-pathogenic Mycobacterium smegmatis and purified to near homogeneity. The recombinant enzyme catalyzed the removal of the pyruvyl moiety of chorismate to form p-hydroxybenzoate with an apparent K(m) value for chorismate of 19.7 microm and a k(cat) value of 0.102 s(-1). Strong inhibition of the reaction by p-hydroxybenzoate but not by pyruvate was observed. These results establish Rv2949c as a chorismate pyruvate-lyase responsible for the direct conversion of chorismate to p-hydroxybenzoate and identify Rv2949c as the sole enzymatic source of p-hydroxybenzoic acid in M. tuberculosis.


Subject(s)
Mycobacterium tuberculosis/enzymology , Parabens/metabolism , Chorismic Acid/metabolism , DNA Transposable Elements/genetics , Escherichia coli/genetics , Methylation , Mutation , Mycobacterium smegmatis/genetics , Mycobacterium tuberculosis/genetics , Oxo-Acid-Lyases/genetics , Oxo-Acid-Lyases/metabolism , Parabens/chemistry , Phenotype , Polyketide Synthases/genetics , Pyruvic Acid/metabolism , Recombinant Proteins/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
SELECTION OF CITATIONS
SEARCH DETAIL
...